How South Korea turbocharged specialty syringe production for COVID-19 vaccines

Une « information » trouvée sur le net vous semble douteuse ?
Utilisez d’abord les boites de recherches "forum" en haut de cette page et "article" sur la page d'accueil, puis posez ici la question aux bénévoles de la Hoaxteam.
SVP : soyez explicite dans le titre du message et donnez vos sources : URL, copie du mail...
Répondre
gmong
Messages : 71
Inscription : jeu. févr. 11, 2021 10:40 am

How South Korea turbocharged specialty syringe production for COVID-19 vaccines

Message par gmong » jeu. avr. 22, 2021 5:37 am

How South Korea turbocharged specialty syringe production for COVID-19 vaccines

Image

It was 7.30am on เกม slotxo Christmas Eve when Cha Jung-hoon, South Korea's deputy minister for small businesses, got a call from his boss to make an urgent three-hour car trip to visit syringe maker Poonglim Pharmatech.

The brief: Work out how the government could convince and aid Poonglim, which had only about 80 employees, to rapidly scale up production of their low dead space (LDS) syringes, a type of syringe designed to minimise the amount of a drug left in the device after injection.

"It might help us get more vaccines," Cha recalls then-minister Park Young-sun telling him.

Under fire in local media for not doing enough to secure COVID-19 vaccines, South Korea's government had been reviewing options to accelerate shipments and gain more supply. Engineering a jump in LDS syringe output was an opportunity to be seized, it concluded.

The niche products were suddenly in huge demand globally after it became apparent they could be used to squeeze out a sixth dose from vials of Pfizer-BioNTech's newly approved COVID-19 vaccine compared to five doses with a standard syringe.

"It had come to our attention that Pfizer was looking for LDS syringes ... using LDS syringes automatically boosts vaccine volume by 20 per cent," Park told Reuters.

Répondre